Literature DB >> 2964565

Clinical and neuropathologic assessment of severity in Huntington's disease.

R H Myers1, J P Vonsattel, T J Stevens, L A Cupples, E P Richardson, J B Martin, E D Bird.   

Abstract

Clinical records were evaluated for 163 Huntington's disease patients in whom postmortem brain specimens had been graded for degree of neuropathologic involvement in the striatum. Juvenile/adolescent onset (4 to 19 years of age) was associated with very severe neuropathologic involvement produced by an apparent rapid degenerative process. Cases of early (20 to 34 years) and midlife (35 to 49 years) onset had respectively less severe striatal involvement, suggesting a slower degenerative progression. High correlations among the grade of neuropathologic involvement, cell counts of neurons, and a rating of physical disability suggest that each represents a common underlying degenerative process of the disease. The relationship between the age at onset and the extent of neuropathologic involvement suggests that a single mechanism may determine both onset and rate of degenerative disease progression.

Entities:  

Mesh:

Year:  1988        PMID: 2964565     DOI: 10.1212/wnl.38.3.341

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  43 in total

1.  Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography.

Authors:  T Postert; B Lack; W Kuhn; M Jergas; J Andrich; B Braun; H Przuntek; R Sprengelmeyer; M Agelink; T Büttner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

Review 2.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

3.  Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

Authors:  C A Gutekunst; S H Li; H Yi; J S Mulroy; S Kuemmerle; R Jones; D Rye; R J Ferrante; S M Hersch; X J Li
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

4.  Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative.

Authors:  Andrew T N Tebbenkamp; Cameron Green; Guilian Xu; Eileen M Denovan-Wright; Aaron C Rising; Susan E Fromholt; Hilda H Brown; Debbie Swing; Ronald J Mandel; Lino Tessarollo; David R Borchelt
Journal:  Hum Mol Genet       Date:  2011-04-22       Impact factor: 6.150

Review 5.  Imaging in cell-based therapy for neurodegenerative diseases.

Authors:  Deniz Kirik; Nathalie Breysse; Tomas Björklund; Laurent Besret; Philippe Hantraye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

6.  Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.

Authors:  Wenzhen Duan; Qi Peng; Naoki Masuda; Eric Ford; Erik Tryggestad; Bruce Ladenheim; Ming Zhao; Jean Lud Cadet; John Wong; Christopher A Ross
Journal:  Neurobiol Dis       Date:  2008-03-10       Impact factor: 5.996

7.  Differences in duration of Huntington's disease based on age at onset.

Authors:  T Foroud; J Gray; J Ivashina; P M Conneally
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

8.  Assessment of cortical and striatal involvement in 523 Huntington disease brains.

Authors:  Tiffany C Hadzi; Audrey E Hendricks; Jeanne C Latourelle; Kathryn L Lunetta; L Adrienne Cupples; Tammy Gillis; Jayalakshmi Srinidhi Mysore; James F Gusella; Marcy E MacDonald; Richard H Myers; Jean-Paul Vonsattel
Journal:  Neurology       Date:  2012-10-03       Impact factor: 9.910

9.  Improving grain yield, stress resilience and quality of bread wheat using large-scale genomics.

Authors:  Philomin Juliana; Jesse Poland; Julio Huerta-Espino; Sandesh Shrestha; José Crossa; Leonardo Crespo-Herrera; Fernando Henrique Toledo; Velu Govindan; Suchismita Mondal; Uttam Kumar; Sridhar Bhavani; Pawan K Singh; Mandeep S Randhawa; Xinyao He; Carlos Guzman; Susanne Dreisigacker; Matthew N Rouse; Yue Jin; Paulino Pérez-Rodríguez; Osval A Montesinos-López; Daljit Singh; Mohammad Mokhlesur Rahman; Felix Marza; Ravi Prakash Singh
Journal:  Nat Genet       Date:  2019-09-23       Impact factor: 38.330

10.  Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.

Authors:  Shuqiu Zheng; Erin B D Clabough; Sovan Sarkar; Marie Futter; David C Rubinsztein; Scott O Zeitlin
Journal:  PLoS Genet       Date:  2010-02-05       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.